首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2294篇
  免费   188篇
  国内免费   26篇
耳鼻咽喉   24篇
儿科学   22篇
妇产科学   2篇
基础医学   294篇
口腔科学   20篇
临床医学   230篇
内科学   849篇
皮肤病学   4篇
神经病学   77篇
特种医学   49篇
外国民族医学   1篇
外科学   324篇
综合类   243篇
预防医学   38篇
眼科学   207篇
药学   53篇
  2篇
中国医学   57篇
肿瘤学   12篇
  2024年   2篇
  2023年   82篇
  2022年   99篇
  2021年   135篇
  2020年   133篇
  2019年   123篇
  2018年   98篇
  2017年   102篇
  2016年   62篇
  2015年   73篇
  2014年   155篇
  2013年   128篇
  2012年   87篇
  2011年   97篇
  2010年   95篇
  2009年   91篇
  2008年   95篇
  2007年   84篇
  2006年   79篇
  2005年   81篇
  2004年   79篇
  2003年   52篇
  2002年   40篇
  2001年   47篇
  2000年   41篇
  1999年   38篇
  1998年   32篇
  1997年   47篇
  1996年   24篇
  1995年   22篇
  1994年   18篇
  1993年   30篇
  1992年   26篇
  1991年   11篇
  1990年   16篇
  1989年   16篇
  1988年   10篇
  1987年   7篇
  1986年   9篇
  1985年   7篇
  1984年   4篇
  1983年   7篇
  1982年   9篇
  1981年   6篇
  1980年   5篇
  1978年   2篇
  1974年   1篇
  1973年   1篇
排序方式: 共有2508条查询结果,搜索用时 15 毫秒
51.
52.
53.
This review describes the landscape of novel modalities such as cell and gene therapies, viruses, other novel biologics, oligomers, and emerging technologies, including modern analytics. We summarize the regulatory history and recent landmark developments in some major markets and examine specific chemistry, manufacturing, and controls (CMC) challenges, including suggestions for exploration of potential science-based approaches in support of regulatory strategy development from an industry perspective. In addition, we evaluate the economic factors contributing to patient access to innovation and discuss the impact of regulation. There is a desperate need for a consistent form of regulation where global approaches to regulatory strategies can be harmonized, and specific CMC challenges can be dealt with using the appropriate science and risk-based tools. Although these tools are well described in current guidance documents, the specifics of applicability to complex novel modalities can still result in differing regulatory advice and outcomes. The future goals for efficiently regulating innovative modalities and technologies could be aided by more regulatory harmonization, regulatory education, and industry cooperation through consortia, enabling industry to supply key information to regulators in a transparent yet well-defined manner, and utilizing mutually understood risk-benefit analyses to produce drugs with appropriate safety, efficacy, and quality characteristics.  相似文献   
54.
  1. Download : Download high-res image (246KB)
  2. Download : Download full-size image
  相似文献   
55.
56.
By realizing the feedback paths over communication networks, we get a class of networked control systems (NCSs), where the network's quality‐of‐service (QoS) is commonly characterized by the average dropout rate of feedback data packets. The control performance of an NCS however, is determined not only by the average dropout rate but also by the dropout pattern of feedback data packets. This paper provides a systematic way to determine the optimal dropout pattern (policy) under a given average dropout rate, where the performance is measured by the output signal power under an exogenous white noise. By modeling the finite‐memory dropout policies with the general Markov chain, this paper formulates the optimal dropout policy design into the optimization of parameters of a dropout Markov chain. That optimization is first solved by an augmented Lagrangian gradient method, which may be stuck at local optima because of the problem's non‐convexity. To compensate this weakness, we apply the branch‐and‐bound method to the optimization whose constraints are bilinear. The branch‐and‐bound method can approach the global optimal solution with any desired tolerance in finite steps. The obtained optimal dropout policy may be interpreted as a network's QoS constraint whose enforcement provides a hard guarantee on the control system's performance. An example is used to illustrate the effectiveness of the achieved results. Copyright © 2012 John Wiley & Sons, Ltd.  相似文献   
57.
58.
《急性病杂志》2014,3(1):69-71
Evaluation of arrhythmias, especially in the acute setting can be challenging. One of the most crucial steps is to accurately differentiate whether a tachyarrhythmia is of supraventricular (with aberrant conduction) or ventricular origin. A 12-lead electrocardiogram may be useful in some cases where specific morphology or features can be sought.  相似文献   
59.
60.
《Heart rhythm》2022,19(1):13-21
  1. Download : Download high-res image (371KB)
  2. Download : Download full-size image
  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号